Travatan Z



Indications and Reactions:

Role Indications Reactions
Primary
Glaucoma 44.4%
Open Angle Glaucoma 25.3%
Normal Tension Glaucoma 15.2%
Intraocular Pressure Increased 9.1%
Angle Closure Glaucoma 2.0%
Ocular Hypertension 2.0%
Abnormal Sensation In Eye 1.0%
Type 2 Diabetes Mellitus 1.0%
Vision Blurred 13.0%
Ocular Hyperaemia 10.1%
Macular Oedema 8.7%
Visual Acuity Reduced 8.7%
Intraocular Pressure Increased 7.2%
Uveitis 7.2%
Retinal Haemorrhage 5.8%
Arrhythmia 4.3%
Eye Pain 4.3%
Fatigue 4.3%
Cataract 2.9%
Detachment Of Retinal Pigment Epithelium 2.9%
Drug Ineffective 2.9%
Hypoaesthesia 2.9%
Optic Nerve Injury 2.9%
Scratch 2.9%
Tinnitus 2.9%
Ulcerative Keratitis 2.9%
Adverse Drug Reaction 1.4%
Anxiety 1.4%
Secondary
Glaucoma 40.5%
Product Used For Unknown Indication 15.5%
Drug Use For Unknown Indication 7.1%
Hypertension 7.1%
Diabetes Mellitus 4.8%
Intraocular Pressure Increased 3.6%
Parkinson's Disease 3.6%
Blood Cholesterol Increased 2.4%
Dysuria 2.4%
Gastrooesophageal Reflux Disease 2.4%
Hypothyroidism 2.4%
Anxiety 1.2%
Depression 1.2%
Headache 1.2%
Hormone Replacement Therapy 1.2%
Hyperuricaemia 1.2%
Open Angle Glaucoma 1.2%
Prostate Cancer 1.2%
Intraocular Pressure Increased 8.3%
Ocular Hyperaemia 8.3%
Retinitis 8.3%
Vision Blurred 8.3%
Arthralgia 4.2%
Blood Pressure Decreased 4.2%
Deafness 4.2%
Drug Hypersensitivity 4.2%
Drug Ineffective 4.2%
Eye Discharge 4.2%
Eye Irritation 4.2%
Eye Pruritus 4.2%
Foreign Body Sensation In Eyes 4.2%
Growth Of Eyelashes 4.2%
Haematochezia 4.2%
Hallucination, Visual 4.2%
Heart Rate Increased 4.2%
Intraocular Pressure Decreased 4.2%
Macular Oedema 4.2%
Medication Error 4.2%
Concomitant
Product Used For Unknown Indication 41.2%
Glaucoma 16.9%
Cardiac Failure 11.1%
Hypertension 5.1%
Blood Cholesterol Increased 2.4%
Cerebral Artery Embolism 2.2%
Constipation 2.0%
Hypothyroidism 1.9%
Breast Cancer 1.7%
Dry Eye 1.7%
Dizziness 1.5%
Osteoporosis 1.5%
Rheumatoid Arthritis 1.5%
Ventricular Fibrillation 1.5%
Atrial Fibrillation 1.4%
Cardiac Failure Chronic 1.4%
Intraocular Pressure Increased 1.4%
Diabetes Mellitus 1.3%
Drug Use For Unknown Indication 1.3%
Chronic Obstructive Pulmonary Disease 1.1%
Pruritus 9.3%
Asthenia 7.4%
Ocular Hyperaemia 7.4%
Vision Blurred 7.4%
Anaphylactic Reaction 5.6%
Dizziness 5.6%
Fatigue 5.6%
Urinary Tract Infection 5.6%
Visual Impairment 5.6%
Angina Pectoris 3.7%
Arthralgia 3.7%
Bronchitis 3.7%
Cholangitis 3.7%
Dehydration 3.7%
Drug Effect Decreased 3.7%
Drug Ineffective 3.7%
Flushing 3.7%
Intraocular Pressure Increased 3.7%
Lacrimation Increased 3.7%
Melaena 3.7%